
<!DOCTYPE html>
<html lang="en" class="govuk-template ">
  <head>
    <meta charset="utf-8" />
    <title>
  UK NSC Beta
</title>
    <meta name="viewport" content="width=device-width, initial-scale=1, viewport-fit=cover">
    <meta name="theme-color" content="#0b0c0c" />

    <meta http-equiv="X-UA-Compatible" content="IE=edge" />


      <link rel="shortcut icon" sizes="16x16 32x32 48x48" href="/assets/images/favicon.ico" type="image/x-icon" />
      <link rel="mask-icon" href="/assets/images/govuk-mask-icon.svg" color="#0b0c0c">
      <link rel="apple-touch-icon" sizes="180x180" href="/assets/images/govuk-apple-touch-icon-180x180.png">
      <link rel="apple-touch-icon" sizes="167x167" href="/assets/images/govuk-apple-touch-icon-167x167.png">
      <link rel="apple-touch-icon" sizes="152x152" href="/assets/images/govuk-apple-touch-icon-152x152.png">
      <link rel="apple-touch-icon" href="/assets/images/govuk-apple-touch-icon.png">



  <link href="/public/stylesheets/unbranded.css" media="screen" rel="stylesheet" type="text/css">
  <link href="/public/stylesheets/phe-nsc-alpha.css" media="screen" rel="stylesheet" type="text/css">



    <meta property="og:image" content="/assets/images/govuk-opengraph-image.png">
  </head>
  <body class="govuk-template__body ">
    <script>document.body.className = ((document.body.className) ? document.body.className + ' js-enabled' : 'js-enabled');</script>



      <a href="#main-content" class="govuk-skip-link">Skip to main content</a>







  <header class="govuk-header " role="banner" data-module="header">
  <div class="govuk-header__container govuk-width-container">

    <div class="govuk-header__logo">
      <a href="/" class="govuk-header__link govuk-header__link--homepage">
        <span class="govuk-header__logotype">

          <svg
            role="presentation"
            focusable="false"
            class="govuk-header__logotype-crown"
            xmlns="http://www.w3.org/2000/svg"
            viewbox="0 0 132 97"
            height="32"
            width="36"
          >
            <path
              fill="currentColor" fill-rule="evenodd"
              d="M25 30.2c3.5 1.5 7.7-.2 9.1-3.7 1.5-3.6-.2-7.8-3.9-9.2-3.6-1.4-7.6.3-9.1 3.9-1.4 3.5.3 7.5 3.9 9zM9 39.5c3.6 1.5 7.8-.2 9.2-3.7 1.5-3.6-.2-7.8-3.9-9.1-3.6-1.5-7.6.2-9.1 3.8-1.4 3.5.3 7.5 3.8 9zM4.4 57.2c3.5 1.5 7.7-.2 9.1-3.8 1.5-3.6-.2-7.7-3.9-9.1-3.5-1.5-7.6.3-9.1 3.8-1.4 3.5.3 7.6 3.9 9.1zm38.3-21.4c3.5 1.5 7.7-.2 9.1-3.8 1.5-3.6-.2-7.7-3.9-9.1-3.6-1.5-7.6.3-9.1 3.8-1.3 3.6.4 7.7 3.9 9.1zm64.4-5.6c-3.6 1.5-7.8-.2-9.1-3.7-1.5-3.6.2-7.8 3.8-9.2 3.6-1.4 7.7.3 9.2 3.9 1.3 3.5-.4 7.5-3.9 9zm15.9 9.3c-3.6 1.5-7.7-.2-9.1-3.7-1.5-3.6.2-7.8 3.7-9.1 3.6-1.5 7.7.2 9.2 3.8 1.5 3.5-.3 7.5-3.8 9zm4.7 17.7c-3.6 1.5-7.8-.2-9.2-3.8-1.5-3.6.2-7.7 3.9-9.1 3.6-1.5 7.7.3 9.2 3.8 1.3 3.5-.4 7.6-3.9 9.1zM89.3 35.8c-3.6 1.5-7.8-.2-9.2-3.8-1.4-3.6.2-7.7 3.9-9.1 3.6-1.5 7.7.3 9.2 3.8 1.4 3.6-.3 7.7-3.9 9.1zM69.7 17.7l8.9 4.7V9.3l-8.9 2.8c-.2-.3-.5-.6-.9-.9L72.4 0H59.6l3.5 11.2c-.3.3-.6.5-.9.9l-8.8-2.8v13.1l8.8-4.7c.3.3.6.7.9.9l-5 15.4v.1c-.2.8-.4 1.6-.4 2.4 0 4.1 3.1 7.5 7 8.1h.2c.3 0 .7.1 1 .1.4 0 .7 0 1-.1h.2c4-.6 7.1-4.1 7.1-8.1 0-.8-.1-1.7-.4-2.4V34l-5.1-15.4c.4-.2.7-.6 1-.9zM66 92.8c16.9 0 32.8 1.1 47.1 3.2 4-16.9 8.9-26.7 14-33.5l-9.6-3.4c1 4.9 1.1 7.2 0 10.2-1.5-1.4-3-4.3-4.2-8.7L108.6 76c2.8-2 5-3.2 7.5-3.3-4.4 9.4-10 11.9-13.6 11.2-4.3-.8-6.3-4.6-5.6-7.9 1-4.7 5.7-5.9 8-.5 4.3-8.7-3-11.4-7.6-8.8 7.1-7.2 7.9-13.5 2.1-21.1-8 6.1-8.1 12.3-4.5 20.8-4.7-5.4-12.1-2.5-9.5 6.2 3.4-5.2 7.9-2 7.2 3.1-.6 4.3-6.4 7.8-13.5 7.2-10.3-.9-10.9-8-11.2-13.8 2.5-.5 7.1 1.8 11 7.3L80.2 60c-4.1 4.4-8 5.3-12.3 5.4 1.4-4.4 8-11.6 8-11.6H55.5s6.4 7.2 7.9 11.6c-4.2-.1-8-1-12.3-5.4l1.4 16.4c3.9-5.5 8.5-7.7 10.9-7.3-.3 5.8-.9 12.8-11.1 13.8-7.2.6-12.9-2.9-13.5-7.2-.7-5 3.8-8.3 7.1-3.1 2.7-8.7-4.6-11.6-9.4-6.2 3.7-8.5 3.6-14.7-4.6-20.8-5.8 7.6-5 13.9 2.2 21.1-4.7-2.6-11.9.1-7.7 8.8 2.3-5.5 7.1-4.2 8.1.5.7 3.3-1.3 7.1-5.7 7.9-3.5.7-9-1.8-13.5-11.2 2.5.1 4.7 1.3 7.5 3.3l-4.7-15.4c-1.2 4.4-2.7 7.2-4.3 8.7-1.1-3-.9-5.3 0-10.2l-9.5 3.4c5 6.9 9.9 16.7 14 33.5 14.8-2.1 30.8-3.2 47.7-3.2z"
            ></path>

            <image src="/assets/images/govuk-logotype-crown.png" xlink:href="" class="govuk-header__logotype-crown-fallback-image" width="36" height="32"></image>
          </svg>
          <span class="govuk-header__logotype-text">
            GOV.UK
          </span>
        </span>

      </a>
    </div>

  </div>
</header>




      <div class="govuk-width-container">

        <main class="govuk-main-wrapper " id="main-content" role="main">


    <div class="govuk-grid-row">
      <div class="govuk-grid-column-two-thirds">
          <a href="search" class="govuk-back-link">Back</a>
        <h1 class="govuk-heading-xl">
            <span class="govuk-caption-l">Adult screening programme</span>
              Spinal Muscular Atrophy (SMA)

        <h2 class="govuk-heading-m">Recommendation</h2>
        <p class="govuk-body govuk-!-font-weight-bold recommendation-badge">
          <span id="not-recommended">Screening is not currently recommended for this condition</span>
        </p>

        <p class="govuk-body">
          Following a review of the evidence against strict criteria, the UK NSC does not currently recommend introducing a national screening programme for carrier or new-born screening for spinal muscular atrophy.
        </p>

        <p class="govuk-body">
          Key findings supporting the UK NSC recommendation:
        </p>

        <ul class="govuk-list govuk-list--bullet">
         <li>there was very limited evidence about how acceptable a screening programme would be</li>
         <li>there was no evidence on how to support individuals who need to make difficult decisions following carrier screening</li>
         <li>there was a lack of information on the reliability of screening tests for SMA</li>
         <li>no effective treatments for SMA were identified in an unsymptomatic population, currently only palliative support can be offered - however, the review identified evidence on a new treatment for SMA, called nusinersen, that can improve symptoms in children with SMA</li>
         <li>this evidence review did not find information on the effectiveness of nusinersen in children without symptoms, and there is no evidence on the long term effects of this drug</li>
        </ul>

        <h2 class="govuk-heading-m">Review cycle</h2>
        <p class="govuk-body">Last review completed: 2016</p>
        <p class="govuk-body">Next review estimated to be completed: 2019 to 2020</p>

        <h2 class="govuk-heading-m">More about Spinal Muscular Atrophy</h2>
        <p class="govuk-body">
          Spinal muscular atrophy (SMA) is a genetic disease that causes muscle weakness and a progressive loss of movement. There is no cure but therapy and support are available to help manage the condition.
        </p>

        <p class="govuk-body">
          <a href="#" class="govuk-link">Read more on NHS UK</a>
        </p>

        <h2 class="govuk-heading-m">Supporting documents</h2>
        <a class="govuk-link" href="#" style="font-size: 20px;">Last evidence review</a>
        <p class="govuk-body-m">
        This is the previous evidence review conducted to investigate whether the condition should be screened or not
        </p>


        <a class="govuk-link" href="#" style="font-size: 20px;">Last evidence review summary</a>
        <br>
        <p class="govuk-body-m">This is the most recent evidence review plus consultation responses
        </p>


        <h2 class="govuk-heading-m">Organisations interested in Spinal Muscular Atrophy</h2>
        <p class="govuk-body">
          These organisations have expressed interest in this recommendation and may submit responses to evidence reviews.
        </p>

        <details class="govuk-details" data-module="govuk-details">
  <summary class="govuk-details__summary">
    <span class="govuk-details__summary-text">
      List of organisations
    </span>
  </summary>
  <div class="govuk-details__text">
    <ul class="govuk-list">
      <li>
        <a class="govuk-link" href="#">The British Society for Human Genetics</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Faculty of Public Health</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Muscular Dystrophy Campaign</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Royal College of General Practitioners</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Royal College of Paediatrics and Child Health</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Royal College of Physicians</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Royal College of Physicians and Surgeons of Glasgow</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Royal College of Physicians of Edinburgh</a>
      </li>
      <li>
        <a class="govuk-link" href="#">SMA Trust</a>
      </li>
      <li>
        <a class="govuk-link" href="#">Spinal Muscular Atrophy Support UK</a>
      </li>
    </ul>
  </div>
</details>

        <p class="govuk-body">
          The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please <a class="govuk-link" href="#">contact us</a>. More information for stakeholders can be found in appendix C of the <a class="govuk-link" href="#">UK NSC evidence review process</a>.
        </p>

      </div>
    </div>

  </main>
</div>


        </main>
      </div>



    <footer class="govuk-footer " role="contentinfo">
  <div class="govuk-width-container ">

    <div class="govuk-footer__meta">
      <div class="govuk-footer__meta-item govuk-footer__meta-item--grow">

          <h2 class="govuk-visually-hidden">Support links</h2>

            <ul class="govuk-footer__inline-list">

                <li class="govuk-footer__inline-list-item">
                  <a class="govuk-footer__link" href="/prototype-admin/clear-data">
                    Clear data
                  </a>
                </li>

            </ul>



        <svg
          role="presentation"
          focusable="false"
          class="govuk-footer__licence-logo"
          xmlns="http://www.w3.org/2000/svg"
          viewbox="0 0 483.2 195.7"
          height="17"
          width="41"
        >
          <path
            fill="currentColor"
            d="M421.5 142.8V.1l-50.7 32.3v161.1h112.4v-50.7zm-122.3-9.6A47.12 47.12 0 0 1 221 97.8c0-26 21.1-47.1 47.1-47.1 16.7 0 31.4 8.7 39.7 21.8l42.7-27.2A97.63 97.63 0 0 0 268.1 0c-36.5 0-68.3 20.1-85.1 49.7A98 98 0 0 0 97.8 0C43.9 0 0 43.9 0 97.8s43.9 97.8 97.8 97.8c36.5 0 68.3-20.1 85.1-49.7a97.76 97.76 0 0 0 149.6 25.4l19.4 22.2h3v-87.8h-80l24.3 27.5zM97.8 145c-26 0-47.1-21.1-47.1-47.1s21.1-47.1 47.1-47.1 47.2 21 47.2 47S123.8 145 97.8 145"
          />
        </svg>
        <span class="govuk-footer__licence-description">
          All content is available under the
          <a
            class="govuk-footer__link"
            href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/"
            rel="license"
          >Open Government Licence v3.0</a>, except where otherwise stated
        </span>
      </div>
      <div class="govuk-footer__meta-item">
        <a
          class="govuk-footer__link govuk-footer__copyright-logo"
          href="https://www.nationalarchives.gov.uk/information-management/re-using-public-sector-information/uk-government-licensing-framework/crown-copyright/"
        >© Crown copyright</a>
      </div>
    </div>
  </div>
</footer>





    <!-- Javascript -->
<script src="/public/javascripts/jquery-1.11.3.js"></script>
<script src="/node_modules/govuk-frontend/all.js"></script>
<script src="/public/javascripts/application.js"></script>


  <script src="/public/javascripts/auto-store-data.js"></script>




  <!-- GOV.UK Prototype Kit v8.11.0 -->

  </body>
</html>
